2 active not recruiting, 1 recruiting, 1 unknown. 2 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Active not recruiting 2 |
| Phase 3 | 1 | Unknown 1 |
Follow Immunotherapeutic Agent: new trials by email Literature Review of Immunotherapeutic Agent trials Research Report on Immunotherapeutic Agent
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy radiotherapy, Platinum-Based Drug, Immunotherapy - Non-small Cell Lung Cancer Stage III | Phase 3 | Unknown | Zhejiang Cancer Hospital | 105 | 2023-09-15 | 2023-09-13 |
| Cryoablation for the Treatment of Metastatic Cancer Core Biopsy, Cryosurgery, Immunotherapeutic Agent - Metastatic Malignant Neoplasm | Not applicable | Active not recruiting | M.D. Anderson Cancer Center | 15 | 2019-12-23 | 2026-08-06 |
| Prospective Collection of Tumor Biopsy and Plasma Samples From Cancer Patients Treated With Molecular Targeted Therapies or Immunotherapy Immunotherapeutic Agent, Molecular Target - Cancer | Not applicable | Active not recruiting | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 200 | 2018-07-11 | 2023-12-11 |
| National Clinical and Biological Sarcoma Database : An Initiative of the French Sarcoma Group Chemotherapy, Immunotherapeutic Agent, target treatment - Sarcoma | Recruiting | Institut Bergonié | 150000 | 2010-01-01 | 2025-09-04 |
Carcinoma, Non-Small-Cell Lung (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Radiation Pneumonitis (1) · Sarcoma (1)
Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1) · Institut Bergonié (1) · M.D. Anderson Cancer Center (1) · Zhejiang Cancer Hospital (1)
Belgium (1) · France (1) · United States (1)
Alda L Tam (1) · Axel Le Cesne, MD/PhD (1) · Jean-Yves Blay, MD/PhD (1) · Maud Toulmonde, MD (1) · Xu Yujin, PhD (1)